As of 2026-03-15, the Relative Valuation of Aptose Biosciences Inc (APS.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 2.12 CAD, the upside of Aptose Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-03-11 | -0.06 |
| 2026-03-10 | -0.06 |
| 2026-03-09 | -0.06 |
| 2026-03-06 | -0.06 |
| 2026-03-05 | -0.06 |
| 2026-03-04 | -0.06 |
| 2026-03-03 | -0.06 |
| 2026-03-02 | -0.06 |
| 2026-02-27 | -0.06 |
| 2026-02-26 | -0.06 |
| 2026-02-25 | -0.06 |
| 2026-02-24 | -0.06 |
| 2026-02-23 | -0.06 |
| 2026-02-20 | -0.06 |
| 2026-02-18 | -0.06 |
| 2026-02-17 | -0.06 |
| 2026-02-13 | -0.06 |
| 2026-02-12 | -0.06 |
| 2026-02-11 | -0.06 |
| 2026-02-10 | -0.06 |
| 2026-02-09 | -0.06 |
| 2026-02-06 | -0.06 |
| 2026-02-05 | -0.06 |
| 2026-02-04 | -0.06 |
| 2026-02-03 | -0.06 |
| 2026-02-02 | -0.06 |
| 2026-01-30 | -0.06 |
| 2026-01-29 | -0.06 |
| 2026-01-28 | -0.06 |
| 2026-01-27 | -0.06 |
| 2026-01-26 | -0.06 |
| 2026-01-23 | -0.06 |
| 2026-01-21 | -0.06 |
| 2026-01-20 | -0.06 |
| 2026-01-16 | -0.06 |
| 2026-01-15 | -0.06 |
| 2026-01-14 | -0.06 |
| 2026-01-13 | -0.06 |
| 2026-01-12 | -0.06 |
| 2026-01-09 | -0.06 |
| 2026-01-07 | -0.06 |
| 2026-01-06 | -0.06 |
| 2026-01-05 | -0.05 |
| 2026-01-02 | -0.05 |
| 2025-12-31 | -0.06 |
| 2025-12-30 | -0.05 |
| 2025-12-24 | -0.05 |
| 2025-12-23 | -0.06 |
| 2025-12-22 | -0.05 |
| 2025-12-19 | -0.05 |